is it better to microdose retatrutide vs. Tirzepatide: What's the Difference? Retatrutide Significantly Reduces Visceral Fat
Description
Sarafidis P, Ortiz A, Ferro CJ et al

Intentional Weight Loss and Obesity-Related Cancer Risk

We build platforms that understand the specific biological timeline of therapy

Tirzepatide, a dual agonist for GLP-1 and GIP receptors, effectively promotes weight loss and improves metabolic parameters by influencing insulin secretion, appetite regulation, and gastric emptying

Diabetes Obes Metab 16(5):403409

J Clin Endocrinol Metab 1969;29:346-51.PubMed 145
